Michele Favia, Elena Lupi, Michela Sperandeo, Lidia Di Cerbo, Antonella Sabia, Barbara Ruozi, Ilaria Ottonelli, Antonietta Curatola, Davide Zanon, Rina Campopiano, Marcello Pani, Domenico Tarantino
{"title":"LAT凝胶:从Galenical实验室到儿科急诊室-一个基金会的政策,Gemelli IRCCS经验。","authors":"Michele Favia, Elena Lupi, Michela Sperandeo, Lidia Di Cerbo, Antonella Sabia, Barbara Ruozi, Ilaria Ottonelli, Antonietta Curatola, Davide Zanon, Rina Campopiano, Marcello Pani, Domenico Tarantino","doi":"10.1177/00185787251337620","DOIUrl":null,"url":null,"abstract":"<p><p><b>Objectives:</b> Lacerations are one of the most widespread and common emergencies among children, addressed by doctors in emergency room admissions. The aim of this study was to optimize the formulation of a pre-existing anaesthetic gel known as LAT gel (Lidocaine 4%, Adrenaline 0.05%, Tetracaine 0.5% gel), in order to allow the paediatric emergency department of the Policlinico A. Gemelli (Rome) to improve the management of lacerations, while avoiding the mandatory use of infiltrative anaesthesia. The aim of the study was also to assess the stability over time of the active ingredients (lidocaine, adrenaline, tetracaina) in the galenic preparation. <b>Methods:</b> LAT gel is a formulation prepared using: a poloxamer, Lutrol F127 (or Kolliphor P407), two anaesthetics (lidocaine and tetracaine), together with adrenaline. The formulation was prepared in a Grade A laminar flow hood and in a Grade B environment for microbial load. Batches were subjected to microbiological analysis by hospital hygiene as indicated in FU XII (\"Official Italian pharmacopoeia XII edition\"). The chemical stability of the gel was assessed by high-performance liquid chromatography. <b>Results</b>: Analysis showed that the lidocaine, tetracaine and adrenaline content in the LAT gel remained constant when stored in a refrigerator at 2 to 8°C for up to 120 days. The non-need for additional anaesthetic methods was considered as a parameter of effectiveness. 83 children were evaluated. In the cases recorded, 83.1% (69/83) of patients did not require an additional anaesthesia. Patients who required additional anaesthesia 16.9% (14/83) were those with deep and extensive lacerations. The results show that an effective, sterile, stable preparation with excellent applicability was prepared. <b>Conclusion:</b> This product lends itself to application to the wound surface with a better anaesthetic and haemostatic effect and, unlike injectable lidocaine, is an optimal treatment for increasing compliance in paediatric emergency rooms.</p>","PeriodicalId":13002,"journal":{"name":"Hospital Pharmacy","volume":" ","pages":"00185787251337620"},"PeriodicalIF":0.7000,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12176776/pdf/","citationCount":"0","resultStr":"{\"title\":\"LAT Gel: from the Galenical Laboratory to the Paediatric Emergency Room - A Fondazione Policlinico Gemelli IRCCS Experience.\",\"authors\":\"Michele Favia, Elena Lupi, Michela Sperandeo, Lidia Di Cerbo, Antonella Sabia, Barbara Ruozi, Ilaria Ottonelli, Antonietta Curatola, Davide Zanon, Rina Campopiano, Marcello Pani, Domenico Tarantino\",\"doi\":\"10.1177/00185787251337620\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Objectives:</b> Lacerations are one of the most widespread and common emergencies among children, addressed by doctors in emergency room admissions. The aim of this study was to optimize the formulation of a pre-existing anaesthetic gel known as LAT gel (Lidocaine 4%, Adrenaline 0.05%, Tetracaine 0.5% gel), in order to allow the paediatric emergency department of the Policlinico A. Gemelli (Rome) to improve the management of lacerations, while avoiding the mandatory use of infiltrative anaesthesia. The aim of the study was also to assess the stability over time of the active ingredients (lidocaine, adrenaline, tetracaina) in the galenic preparation. <b>Methods:</b> LAT gel is a formulation prepared using: a poloxamer, Lutrol F127 (or Kolliphor P407), two anaesthetics (lidocaine and tetracaine), together with adrenaline. The formulation was prepared in a Grade A laminar flow hood and in a Grade B environment for microbial load. Batches were subjected to microbiological analysis by hospital hygiene as indicated in FU XII (\\\"Official Italian pharmacopoeia XII edition\\\"). The chemical stability of the gel was assessed by high-performance liquid chromatography. <b>Results</b>: Analysis showed that the lidocaine, tetracaine and adrenaline content in the LAT gel remained constant when stored in a refrigerator at 2 to 8°C for up to 120 days. The non-need for additional anaesthetic methods was considered as a parameter of effectiveness. 83 children were evaluated. In the cases recorded, 83.1% (69/83) of patients did not require an additional anaesthesia. Patients who required additional anaesthesia 16.9% (14/83) were those with deep and extensive lacerations. The results show that an effective, sterile, stable preparation with excellent applicability was prepared. <b>Conclusion:</b> This product lends itself to application to the wound surface with a better anaesthetic and haemostatic effect and, unlike injectable lidocaine, is an optimal treatment for increasing compliance in paediatric emergency rooms.</p>\",\"PeriodicalId\":13002,\"journal\":{\"name\":\"Hospital Pharmacy\",\"volume\":\" \",\"pages\":\"00185787251337620\"},\"PeriodicalIF\":0.7000,\"publicationDate\":\"2025-06-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12176776/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Hospital Pharmacy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/00185787251337620\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hospital Pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/00185787251337620","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
摘要
目的:撕裂伤是儿童中最普遍和最常见的紧急情况之一,由医生在急诊室入院时处理。本研究的目的是优化预先存在的麻醉凝胶LAT凝胶(利多卡因4%,肾上腺素0.05%,丁卡因0.5%凝胶)的配方,以使polilinico a. Gemelli(罗马)的儿科急诊科能够改善对撕裂伤的管理,同时避免强制使用浸润麻醉。该研究的目的还在于评估盖伦制剂中活性成分(利多卡因、肾上腺素、丁卡因)随时间的稳定性。方法:LAT凝胶是用泊洛沙姆、Lutrol F127(或Kolliphor P407)、两种麻醉剂(利多卡因和丁卡因)和肾上腺素配制而成的制剂。该制剂在a级层流罩和B级微生物负荷环境中制备。批次按照FU XII(“意大利官方药典第十二版”)的规定进行医院卫生学微生物分析。采用高效液相色谱法测定凝胶的化学稳定性。结果:分析表明,LAT凝胶在2 ~ 8℃的冰箱中保存120天,利多卡因、丁卡因和肾上腺素含量保持不变。不需要额外的麻醉方法被认为是有效性的一个参数。83名儿童接受了评估。在记录的病例中,83.1%(69/83)的患者不需要额外的麻醉。需要额外麻醉的患者16.9%(14/83)是那些有深度和广泛撕裂伤的患者。结果表明,制备出了一种有效、无菌、稳定、适用性好的制剂。结论:该产品适用于伤口表面,具有更好的麻醉和止血效果,与可注射利多卡因不同,是提高儿科急诊室依从性的最佳治疗方法。
LAT Gel: from the Galenical Laboratory to the Paediatric Emergency Room - A Fondazione Policlinico Gemelli IRCCS Experience.
Objectives: Lacerations are one of the most widespread and common emergencies among children, addressed by doctors in emergency room admissions. The aim of this study was to optimize the formulation of a pre-existing anaesthetic gel known as LAT gel (Lidocaine 4%, Adrenaline 0.05%, Tetracaine 0.5% gel), in order to allow the paediatric emergency department of the Policlinico A. Gemelli (Rome) to improve the management of lacerations, while avoiding the mandatory use of infiltrative anaesthesia. The aim of the study was also to assess the stability over time of the active ingredients (lidocaine, adrenaline, tetracaina) in the galenic preparation. Methods: LAT gel is a formulation prepared using: a poloxamer, Lutrol F127 (or Kolliphor P407), two anaesthetics (lidocaine and tetracaine), together with adrenaline. The formulation was prepared in a Grade A laminar flow hood and in a Grade B environment for microbial load. Batches were subjected to microbiological analysis by hospital hygiene as indicated in FU XII ("Official Italian pharmacopoeia XII edition"). The chemical stability of the gel was assessed by high-performance liquid chromatography. Results: Analysis showed that the lidocaine, tetracaine and adrenaline content in the LAT gel remained constant when stored in a refrigerator at 2 to 8°C for up to 120 days. The non-need for additional anaesthetic methods was considered as a parameter of effectiveness. 83 children were evaluated. In the cases recorded, 83.1% (69/83) of patients did not require an additional anaesthesia. Patients who required additional anaesthesia 16.9% (14/83) were those with deep and extensive lacerations. The results show that an effective, sterile, stable preparation with excellent applicability was prepared. Conclusion: This product lends itself to application to the wound surface with a better anaesthetic and haemostatic effect and, unlike injectable lidocaine, is an optimal treatment for increasing compliance in paediatric emergency rooms.
期刊介绍:
Hospital Pharmacy is a monthly peer-reviewed journal that is read by pharmacists and other providers practicing in the inpatient and outpatient setting within hospitals, long-term care facilities, home care, and other health-system settings The Hospital Pharmacy Assistant Editor, Michael R. Cohen, RPh, MS, DSc, FASHP, is author of a Medication Error Report Analysis and founder of The Institute for Safe Medication Practices (ISMP), a nonprofit organization that provides education about adverse drug events and their prevention.